Atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/... — RxCUI 1046787
RxNorm drug concept · Semantic clinical drug
RxCUI 1046787
Semantic clinical drug · SCD
● Current RxNorm concept 8 FDA products
21 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1046787
Official nameAtropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asatropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine hydrobromide 0.0065 MG per 5 ML Oral Solution; PHENobarbital 16.2 MG / hyoscyamine sulfate 0.1037 MG / atropine sulfate 0.0194 MG / scopolamine HBr 0.0065 MG in 5 mL Oral Solution
FDA products mapped8
Package NDCs mapped21
Reported Medicaid activity (SDUD)13 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Phenobarbital: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- Phenobarbital is mainly used to control seizures — including generalized tonic-clonic seizures (sometimes called grand mal seizures) and partial seizures. It's also used as a sedat...
- What is phenobarbital actually used for?
- Please don't stop it on your own. Phenobarbital can cause physical dependence, and stopping it suddenly — especially after taking it for a while — can trigger serious withdrawal sy...
- Can I just stop taking phenobarbital if I feel better?
🕸️ Concept Web — How Atropine sulfate 0.00388 MG/ML / hyoscyamine sul... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution
RxCUI 1046787 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 8
The active substance itself — no strength, form, or brand attached yet.
-
Atropine
1223IN -
Hyoscyamine
153970IN -
Phenobarbital
8134IN -
Scopolamine
9601IN -
Atropine / hyoscyamine / phenobarbital / scopolamine
689606MIN -
Atropine sulfate
153971PIN -
Hyoscyamine sulfate
1225PIN -
Scopolamine hydrobromide
9603PIN
-
Atropine
-
Brand names 2
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Donnatal
115141BN -
Phenohytro
1739882BN
-
Donnatal
-
Dose forms 17
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Atropine / hyoscyamine / phenobarbital / scopolamine Oral Solution
757058SCDF -
Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Oral Solution
2646160SCDFP -
Atropine / hyoscyamine / phenobarbital / scopolamine Oral Liquid Product
1154678SCDG -
Atropine / hyoscyamine / phenobarbital / scopolamine Oral Product
1154679SCDG -
Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Oral Liquid Product
2661753SCDGP -
Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Oral Product
2661270SCDGP -
Atropine / hyoscyamine / phenobarbital / scopolamine Oral Solution [Donnatal]
757066SBDF -
Atropine / hyoscyamine / phenobarbital / scopolamine Oral Solution [Phenohytro]
2048015SBDF - +9 more in this family
-
Atropine / hyoscyamine / phenobarbital / scopolamine Oral Solution
-
Clinical & branded drugs 8
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Atropine sulfate 0.00388 MG/ML
1046784SCDC -
Hyoscyamine sulfate 0.0207 MG/ML
1046785SCDC -
Phenobarbital 3.24 MG/ML
316481SCDC -
Scopolamine hydrobromide 0.0013 MG/ML
1046786SCDC -
Atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution [Donnatal]
1046924SBD -
Atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution [Phenohytro]
2048017SBD -
Atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML [Donnatal]
1046923SBDC -
Atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML [Phenohytro]
2118008SBDC
-
Atropine sulfate 0.00388 MG/ML
Showing up to 8 concepts per family — 26 of 35 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Atropine sulfate 0.00388 MG/ML
SCDC · 1046784 -
Hyoscyamine sulfate 0.0207 MG/ML
SCDC · 1046785 -
Phenobarbital 3.24 MG/ML
SCDC · 316481 -
Scopolamine hydrobromide 0.0013 MG/ML
SCDC · 1046786 -
Atropine / hyoscyamine / phenobarbital / scopolamine Oral Solution
SCDF · 757058 -
Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Oral Solution
SCDFP · 2646160 -
Atropine / hyoscyamine / phenobarbital / scopolamine Oral Liquid Product
SCDG · 1154678 -
Atropine / hyoscyamine / phenobarbital / scopolamine Oral Product
SCDG · 1154679 -
Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Oral Liquid Product
SCDGP · 2661753 -
Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Oral Product
SCDGP · 2661270
Brand-Name Concepts
-
Atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution [Donnatal]
SBD · 1046924 -
Atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution [Phenohytro]
SBD · 2048017 -
Atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML [Donnatal]
SBDC · 1046923 -
Atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML [Phenohytro]
SBDC · 2118008 -
Atropine / hyoscyamine / phenobarbital / scopolamine Oral Solution [Donnatal]
SBDF · 757066 -
Atropine / hyoscyamine / phenobarbital / scopolamine Oral Solution [Phenohytro]
SBDF · 2048015 -
Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Oral Solution [Donnatal]
SBDFP · 2656012 -
Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Oral Solution [Phenohytro]
SBDFP · 2656099 -
Donnatal Oral Liquid Product
SBDG · 1175281 -
Donnatal Oral Product
SBDG · 1175282
📦 FDA Products & Package NDCs
8 products · 21 package NDCs
21 package NDCs map to RxCUI 1046787 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 17856-0125-01 | 72 CUP, UNIT-DOSE in 1 BOX (17856-0125-1) / 10 mL in 1 CUP,... | Phenohytro | ATLANTIC BIOLOGICALS CORP. | 2024-04-08 |
| 17856-0125-02 | 72 CUP, UNIT-DOSE in 1 BOX (17856-0125-2) / 5 mL in 1 CUP,... | Phenohytro | ATLANTIC BIOLOGICALS CORP. | 2024-04-08 |
| 17856-0125-05 | 45 SYRINGE in 1 CASE (17856-0125-5) / 5 mL in 1 SYRINGE | Phenohytro | ATLANTIC BIOLOGICALS CORP. | 2026-05-19 |
| 50742-0665-04 | 118 mL in 1 BOTTLE (50742-665-04) | Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide | Ingenus Pharmaceuticals, LLC | 2021-08-01 |
| 50742-0665-16 | 473 mL in 1 BOTTLE (50742-665-16) | Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide | Ingenus Pharmaceuticals, LLC | 2021-08-01 |
| 50742-0666-04 | 118 mL in 1 BOTTLE (50742-666-04) | Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide | Ingenus Pharmaceuticals, LLC | 2021-08-01 |
| 50742-0666-16 | 473 mL in 1 BOTTLE (50742-666-16) | Phenobarbital, Hyoscyamine Sulfate, Atropine Sulfate, Scopolamine Hydrobromide | Ingenus Pharmaceuticals, LLC | 2021-08-01 |
| 59212-0422-04 | 118 mL in 1 BOTTLE (59212-422-04) | Donnatal | Advanz Pharma (US) Corp. | 1980-12-30 |
| 59212-0422-10 | 10 mL in 1 BOTTLE (59212-422-10) | Donnatal | Advanz Pharma (US) Corp. | 1980-12-30 |
| 59212-0422-16 | 473 mL in 1 BOTTLE (59212-422-16) | Donnatal | Advanz Pharma (US) Corp. | 1980-12-30 |
| 59212-0423-04 | 118 mL in 1 BOTTLE (59212-423-04) | Donnatal | Advanz Pharma (US) Corp. | 1980-12-30 |
| 59212-0423-10 | 10 mL in 1 BOTTLE (59212-423-10) | Donnatal | Advanz Pharma (US) Corp. | 1980-12-30 |
| 59212-0423-16 | 473 mL in 1 BOTTLE (59212-423-16) | Donnatal | Advanz Pharma (US) Corp. | 1980-12-30 |
| 66689-0063-10 | 1 TRAY in 1 CASE (66689-063-10) / 10 CUP, UNIT-DOSE in 1 TR... | Donnatal | VistaPharm, LLC | 2017-10-26 |
| 66689-0063-40 | 4 TRAY in 1 CASE (66689-063-40) / 10 CUP, UNIT-DOSE in 1 TR... | Donnatal | VistaPharm, LLC | 2017-10-26 |
| 66689-0063-50 | 5 TRAY in 1 CASE (66689-063-50) / 10 CUP, UNIT-DOSE in 1 TR... | Donnatal | VistaPharm, LLC | 2017-10-26 |
| 66689-0063-99 | 10 TRAY in 1 CASE (66689-063-99) / 10 CUP, UNIT-DOSE in 1 T... | Donnatal | VistaPharm, LLC | 2017-10-26 |
| 75826-0127-04 | 118 mL in 1 BOTTLE, PLASTIC (75826-127-04) | Phenohytro | Winder Laboratories LLC | 2018-06-25 |
| 75826-0127-16 | 473 mL in 1 BOTTLE, PLASTIC (75826-127-16) | Phenohytro | Winder Laboratories LLC | 2018-06-25 |
| 75826-0128-04 | 118 mL in 1 BOTTLE, PLASTIC (75826-128-04) | Phenohytro | Winder Laboratories LLC | 2018-06-25 |
| 75826-0128-16 | 473 mL in 1 BOTTLE, PLASTIC (75826-128-16) | Phenohytro | Winder Laboratories LLC | 2018-06-25 |
Observed labelers:
Advanz Pharma (US) Corp. (6) ·
Ingenus Pharmaceuticals, LLC (4) ·
VistaPharm, LLC (4) ·
Winder Laboratories LLC (4) ·
ATLANTIC BIOLOGICALS CORP. (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.